




Searching News Database: Osteocel
HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
HSMN NewsFeed - 8 May 2008
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
HSMN NewsFeed - 9 Oct 2007
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Additional items found! 3

Members Archive contains
3 additional stories matching:
Osteocel
(Password required)
Osteocel
(Password required)